Matsuda Masaru

See Remarks | See Remark | SVP And General Counsel +1 more

2 companies

Insider Signal Score

Average

Trades Analyzed

12M Win Rate

33.3%

Avg 3M Return

-13.3%

Avg 12M Return

-25.0%

Matsuda Masaru is a See Remarks at Arcutis Biotherapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $4.1M based on current market prices.

Holdings by Company

ARQT4d ago

Current Shares126.7K

Value$2.62M

Net Activity-146,733

Bought: 5.7KSold: 152.4K

HALOSep 4, 2021

Current Shares23.5K

Value$1.53M

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 4, 2026	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	8,256	$23.31	$192,415.26	-3.1%	-	-
Feb 2, 2026	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	40,638	$25.28	$1,027,292.65	-7.5%	-8.7%	-
Dec 1, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	1,657	$30.23	$50,091.11	-1.1%	-18.5%	-
Nov 19, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	2,550	$28.29	$72,135.10	-0.8%	-4.6%	-
Nov 3, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	7,208	$24.72	$178,155.76	-2.3%	+3.3%	-
Sep 4, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	36,130	$16.16	$583,716.28	-18.3%	+84.8%	-
Aug 4, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	6,330	$14.33	$90,687.38	-3.1%	+70.5%	-
May 28, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	1,800	$13.78	$24,806.52	-0.9%	+16.6%	-
May 2, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	5,030	$15.20	$76,453.49	-2.4%	-4.3%	+53.2%
Mar 3, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	3,263	$13.03	$42,520.48	-1.5%	+5.1%	+83.9%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC